InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Mason Michael, Chief Financial Officer. Officer active across 1 company, notably Karyopharm Therapeutics Inc.. Aggregated, 16 filings have been published. Split: 0 buy · 11 sells. Total volume traded: €113k. Activity tracked since 1 June 2021. The latest transaction was disclosed on 4 September 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Mason Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
7,050 shares@ US$0.72183.1% of flowCommon StockSEC:0000950170-24-104031:0
652 shares@ US$0.990.4% of flowCommon StockSEC:0000950170-24-069860:0
27,687 shares@ US$1.1720.4% of flowCommonSEC:0000950170-24-025191:0
2,545 shares@ US$1.32382.1% of flowCommon StockSEC:0000950170-24-023292:0
4,205 shares@ US$1.58654.2% of flowCommon StockSEC:0000950170-24-012832:0
13,333 shares0Common StockSEC:0000950170-24-007588:0
6,913 shares@ US$1.33135.8% of flowCommon StockSEC:0001209191-23-048162:0
631 shares@ US$2.220.9% of flowCommon StockSEC:0001209191-23-034262:0
95,000 shares0Common StockSEC:0001209191-23-014843:0
2,802 shares@ US$3.03685.5% of flowCommon StockSEC:0001209191-23-014078:0
4,141 shares@ US$3.408.9% of flowCommon StockSEC:0001209191-23-007775:0
30,000 shares0Common StockSEC:0001209191-22-048394:0
598 shares@ US$6.040.0019% mcap4.7% of flowCommon StockSEC:0000899243-22-021234:0
88,200 shares0Common StockSEC:0001209191-22-014628:0
3,947 shares@ US$9.86230.2% of flowCommon StockSEC:0001209191-22-008126:0
5,500 shares0Common StockSEC:0000899243-21-021368:0
16 of 16 declarations
About Mason Michael
Mason Michael is Directeur Financier at Karyopharm Therapeutics Inc., where his listed function is EVP, CFO & Treasurer. Across 16 filings in total, the 16 sampled filings cover the period from 2021-06-01 to 2024-09-05 and consist only of sales, for total sales of EUR 112626.
